Document is current
Any future updates will be listed below
-
Authors
Taieb, Adam Ben
Roberts, Erika
Luckevich, Maria
Larsen, Sara
le Roux, Carel W.
de Freitas, Paulo Gomes
Wolfert, Dingeman
-
Funding
Funding for this research was provided by:
Novo Nordisk A/S
- License Information
-
More Information
Article History
Received: 9 June 2022
Accepted: 18 October 2022
First Online: 7 December 2022
Declarations
:
: Not applicable.
: Not applicable.
: ML is employed by Novo Nordisk Canada Inc., Ontario, Canada, and SL is employed by Novo Nordisk A/S, Søborg, Denmark. ABT, ER, PGF, and DW are employed by Wickenstones Ltd. and received support from Novo Nordisk to complete this SLR. CWR is employed by Diabetes Complications Research Centre, Conway Institute, University College, Dublin, Ireland and did not receive support from Novo Nordisk.
